Esperion Therapeutics ESPR Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Esperion Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Esperion Therapeutics's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Esperion Therapeutics's prepaid & other current?
- Esperion Therapeutics (ESPR) reported prepaid & other current of $6.02M in Q1 2026.
- How has Esperion Therapeutics's prepaid & other current changed year-over-year?
- Esperion Therapeutics's prepaid & other current increased by 25.1% year-over-year, from $4.82M to $6.02M.
- What is the long-term trend for Esperion Therapeutics's prepaid & other current?
- Over 5 years (2020 to 2025), Esperion Therapeutics's prepaid & other current has grown at a -17.2% compound annual growth rate (CAGR), from $11.57M to $4.5M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.